Calif. Reps Call For Probe Of Biovail-Valeant Deal
A pair of California lawmakers is asking the U.S. Department of Justice and the Securities and Exchange Commission to investigate the proposed $3.2 billion merger between U.S.-based Valeant Pharmaceuticals International and...To view the full article, register now.
Already a subscriber? Click here to view full article